Here, transcriptional profiling of the widely used Braf mutant syngeneic YUMM3.3 mouse melanoma model showed that gain of Activin-A secretion enriched MonoMacs population at the expense of neutrophil infiltration already at an early stage of tumor growth. This evidence concerns the gene BRAF and melanoma.